Megan Hooton serves as President of IQVIA Biotech, a specialized business unit within IQVIA dedicated to providing clinical development solutions for biotech and emerging biopharma customers. With more than 30 years of experience in managing global research and development operations across pharmaceutical and biotech sectors, Meg brings a wealth of operational and cross-cultural expertise to her role.